About this Research Topic
The possibility of understanding the microenvironment, i.e., distinguishing from pathological to healthy ones, is essential in the era of personalized medicine. Many targets are successfully exploited in recent years, e.g. FAP, VEGF, and PSMA, for imaging and therapy purposes, paving the way for a new chapter of personalized medicine, i.e., theragnostic approach.
The scope of this section is to provide an overview of advanced tools for imaging the pathological microenvironment by nuclear medicine. The following contributions will have high priority:
• Tracer development and new radiochemistry for developing imaging tools.
• Preclinical studies aimed to introduce feasible animal models aimed to display novel molecular pathological processes by targeting the microenvironment as the basis for human application.
• Translational studies from pre-clinical/in vitro to in vivo application in diagnostic/therapeutic/theragnostics field.
• Clinical research studies about novel or existing radiopharmaceuticals targeting the microenvironment to improve the management of patients.
Keywords: Imaging, Nuclear Medicine, Oncology, Microenvironment, Theragnostics, Radiopharmaceuticals
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.